Quick Answer
Nuo Therapeutics, Inc. reported Gross Profit of $2.22 million for fiscal year 2025.
Nuo Therapeutics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $2.22M | +108.8% |
| 2024 | $1.06M | +120.2% |
| 2023 | $482.4K | +418.5% |
| 2022 | $93.0K | — |
| 2021 | $0.00 | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $31.6K | -97.4% |
| 2018 | $1.21M | +426.4% |
| 2017 | -$370.0K | -110.4% |
| 2015 | $3.54M | +257.5% |
| 2014 | $991.2K | -68.2% |
| 2013 | $3.12M | -53.1% |
| 2012 | $6.65M | +47.1% |
| 2011 | $4.52M | +96.7% |
| 2010 | $2.30M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $625.4K | +131.2% | +15.6% |
| June 30, 2025 | $540.9K | +80.6% | +48.8% |
| March 31, 2025 | $363.4K | +97.5% | +34.4% |
| September 30, 2024 | $270.4K | +51.6% | -9.7% |
| June 30, 2024 | $299.4K | +206.5% | +62.8% |
| March 31, 2024 | $184.0K | +263.0% | +3.1% |
| September 30, 2023 | $178.4K | +461.9% | +82.7% |
| June 30, 2023 | $97.7K | — | +92.7% |
- Nuo Therapeutics, Inc. showed an increase of +108.8% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, Nuo Therapeutics, Inc.’s gross profit has declined by 3.5% (from $2.30 million to $2.22 million).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: